These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14725939)

  • 1. Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors.
    Sayer R; Law E; Connelly PJ; Breen KC
    Clin Biochem; 2004 Feb; 37(2):98-104. PubMed ID: 14725939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of salivary acetylcholinesterase and pseudocholinesterase in patients with Alzheimer's disease: A case-control study.
    Ahmadi-Motamayel F; Goodarzi MT; Tarazi S; Vahabian M
    Spec Care Dentist; 2019 Jan; 39(1):39-44. PubMed ID: 30536408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholinesterase in Alzheimer's disease.
    Talesa VN
    Mech Ageing Dev; 2001 Nov; 122(16):1961-9. PubMed ID: 11589914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholinesterases and their importance in the etiology, diagnosis and therapy of Alzheimer's disease].
    Patocka J; Strunecká A; Rípová D
    Cesk Fysiol; 2001 Feb; 50(1):4-10. PubMed ID: 11268561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer?
    Bakhtiari S; Moghadam NB; Ehsani M; Mortazavi H; Sabour S; Bakhshi M
    J Clin Diagn Res; 2017 Jan; 11(1):ZC58-ZC60. PubMed ID: 28274046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B; Singh N
    Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?
    Macdonald IR; Rockwood K; Martin E; Darvesh S
    J Alzheimers Dis; 2014; 42(2):379-84. PubMed ID: 24898642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lymphocyte dopamine beta-hydroxylase immunoreactivity in Alzheimer's disease: compensatory response to cholinergic deficit?
    Giubilei F; Calderaro C; Antonini G; Sepe-Monti M; Tisei P; Brunetti E; Marchione F; Caronti B; Pontieri FE
    Dement Geriatr Cogn Disord; 2004; 18(3-4):338-41. PubMed ID: 15305112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linarin improves the dyskinesia recovery in Alzheimer's disease zebrafish by inhibiting the acetylcholinesterase activity.
    Pan H; Zhang J; Wang Y; Cui K; Cao Y; Wang L; Wu Y
    Life Sci; 2019 Apr; 222():112-116. PubMed ID: 30802512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholinesterase and its inhibition in Alzheimer disease.
    Lane RM; Kivipelto M; Greig NH
    Clin Neuropharmacol; 2004; 27(3):141-9. PubMed ID: 15190239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
    Giacobini E; Spiegel R; Enz A; Veroff AE; Cutler NR
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1053-65. PubMed ID: 12111443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs.
    Lazarevic-Pasti T; Leskovac A; Momic T; Petrovic S; Vasic V
    Curr Med Chem; 2017; 24(30):3283-3309. PubMed ID: 28685687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease.
    Atukeren P; Cengiz M; Yavuzer H; Gelisgen R; Altunoglu E; Oner S; Erdenen F; Yuceakın D; Derici H; Cakatay U; Uzun H
    Biomed Pharmacother; 2017 Jun; 90():786-795. PubMed ID: 28427041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
    Darreh-Shori T; Hellström-Lindahl E; Flores-Flores C; Guan ZZ; Soreq H; Nordberg A
    J Neurochem; 2004 Mar; 88(5):1102-13. PubMed ID: 15009666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a simple laboratory test for Alzheimer's disease: measuring acetylcholinesterase in saliva - a pilot study.
    Boston PF; Gopalkaje K; Manning L; Middleton L; Loxley M
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):439-40. PubMed ID: 17702052
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary acetylcholinesterase as a biomarker for organophosphate exposure.
    Ng V; Koh D; Wee A; Chia SE
    Occup Med (Lond); 2009 Mar; 59(2):120-2. PubMed ID: 19122189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?
    Sramek JJ; Cutler NR
    Alzheimer Dis Assoc Disord; 2000; 14(4):216-27. PubMed ID: 11186600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.